Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
ICE has grown dramatically in the last five years. The institute now supports 159 scientists working to understand how cells’ fates are determined and harness that information to select, modify and reprogram human cells. While the hallmark of ICE science continues to be basic research, our ultimate goal is to mold engineered human cells into therapies for a wide range of devastating diseases, including Parkinson’s disease, amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), diabetes, and heart failure.
ICE investigators continue to publish breaking discoveries in top-tier journals—more than 60 peer-reviewed articles in the last year alone. Our investigators are recognized internationally in the fields of adult neural and embryonic stem cell biology, neuroprotection and Parkinson’s disease, hypoxia and immunobiology. They also have contributed significantly to improving induced pluripotent stem cell (iPS) technology, which brings us much closer to many applications that use pluripotent stem cells derived from adult cells.
Exciting advances are being made every day at ICE. We welcome you to learn more about our research and the people behind it.
Director, Institute for Cell Engineering
Johns Hopkins Medicine